A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on: Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine.
Read moreIn our latest blog, Community Pharmacy England Committee Member and Regional Representative for Yorkshire and Humber David Broome, provides insight on the key topics discussed at our July Committee meeting. The update explains the urgent matters discussed during the meeting such as the ongoing pressures on community pharmacy businesses and staff, as well as describing
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (21/07/2023) announced the following list of price concessions for July 2023: Please note CPE is still in discussion with DHSC on several other lines of concern, including other
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Atomoxetine 40mg and 60mg capsules. MSN/2023/068 Tier 2 – medium impact Date of issue 21st July 2023 Atomoxetine 40mg and 60mg capsules will be out of stock from late July 2023 until September 2023 Other strengths and formulations of atomoxetine remain
Read moreCommunity Pharmacy England has submitted a full and detailed written response to the Health and Social Care Select Committee’s pharmacy inquiry. The Committee is expected to hold oral evidence sessions when Parliament returns in the Autumn. The commencement of this inquiry follows on from those held on other primary care sectors, including Dentistry and General
Read moreCommunity Pharmacy England met in Leeds for a full Committee Meeting on 12th and 13th July 2023. Committee Members spent time considering urgent matters such as pharmacy pressures and the ongoing Primacy Care Access Plan negotiations, with valuable input from sector polls and LPC leaders. The packed two-day meeting agenda included time to consider both
Read moreCLMR number: CLMR (23)A/05 Date issued: 19 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Diltiazem HCl 2% Cream [unlicensed medicine] – Quantum Pharmaceutical MDR Number: MDR 023-07/23 Company name: Quantum Pharmaceutical Product name: Diltiazem HCl 2% Cream [unlicensed medicine] Lot number/expiry Product name Batch number
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (18/07/2023) announced the following list of price concessions for July 2023: Drug Pack size Price concession Atorvastatin 40mg tablets 28 £2.25 Chloramphenicol 1% eye ointment 4 £5.18 Clarithromycin
Read moreUpdate: (18/07/2023) There will be intermittent supply of GlucaGen® 1mg powder for injection kit until 2024. All stock must be conserved as much as possible and used carefully as outlined in the MSN which can be found on the Specialist Pharmacy Services (SPS) website. Department of Health and Social Care (DHSC) has issued a medicine
Read moreNational Patient Safety Alert: Shortage of pyridostigmine 60mg tablets National Patient Safety Alert Reference Number: NatPSA/2023/008/DHSC Date issued: 18th July 2023 Brief description of the problem There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Supplies are not expected to stabilise to meet full market demand until at least mid-2024.
Read more
